New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission

Stock News01-30

According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the "Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026)." The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the "soliciting opinions" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as "supplementing materials."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1186833842?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-30 20:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186833842","market":"hk","top_or_hot":-1,"title":"New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission","media":"Stock News","content":"<p>According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>New Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNew Stock Alert | Xinji Pharmaceutical, Yifei Technology Among Companies With Hong Kong IPO Applications Accepted by China Securities Regulatory Commission\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-30 20:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1186833842","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186833842","pubTimestamp":1769776456,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159938":"医药","BK1161":"生物科技","09939":"开拓药业-B","BK1574":"生物医药B类股","02565":"派格生物医药-B","BK1515":"抗疫概念"},"translate_title":"新股快讯|香港IPO申请获证监会受理企业中的新济药业、逸飞科技","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"09939":1,"02565":1},"content_text":"According to information obtained by Zhitong Caijing APP, on January 30, the China Securities Regulatory Commission (CSRC) released the \"Status Table for Overseas Securities Issuance and Listing by Domestic Enterprises (Initial Public Offerings and Full Circulation) (As of January 30, 2026).\" The table indicates that the CSRC has received application materials for Hong Kong IPOs from Xinji Pharmaceutical, Yifei Technology, Daoyuan Technology, Chelian Tianxia, Weimai Medical, Jingwang Electronics, Junce Biotech, and Zhuxian Technology. Separately, the filing status for Lao Xiang Ji's (indirect overseas listing) proposed Hong Kong IPO has moved to the \"soliciting opinions\" stage. Meanwhile, the filing status for Xinmai Semiconductor's intended Hong Kong IPO is listed as \"supplementing materials.\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1186833842","isCrawlerRequest":true}